A detailed history of Massmutual Trust CO Fsb transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 523 shares of VNDA stock, worth $2,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
523
Previous 367 42.51%
Holding current value
$2,641
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$4.61 - $6.34 $719 - $989
156 Added 42.51%
523 $2,000
Q4 2023

Jan 03, 2024

SELL
$3.38 - $4.58 $229 - $311
-68 Reduced 15.63%
367 $1,000
Q3 2023

Oct 03, 2023

SELL
$4.28 - $6.57 $2,456 - $3,771
-574 Reduced 56.89%
435 $1,000
Q2 2023

Aug 01, 2023

BUY
$5.9 - $6.95 $5,953 - $7,012
1,009 New
1,009 $6,000
Q3 2022

Oct 07, 2022

BUY
$9.44 - $11.76 $802 - $999
85 New
85 $1,000
Q1 2022

Apr 08, 2022

SELL
$10.84 - $16.55 $390 - $595
-36 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$15.69 - $21.14 $564 - $761
36 New
36 $1,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $286M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.